课题基金 / 基金详情

GOG 162--PHASE III RANDOMIZED TRIAL OF CISPLATIN AND PACLITAXEL--OVARIAN CANCER

GOG 162--PHASE III RANDOMIZED TRIAL OF CISPLATIN AND PACLITAXEL--OVARIAN CANCER
GOG 162——顺铂和紫杉醇的 III 期随机试验——卵巢癌
批准号:
6282251
负责人:
PATRICIA S BRALY
金额:
$1.97万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1999-06-30

项目摘要

项目成果

PATRICIA S BRALY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
GOG 162: This protocol will examine the best way to safely give the two chemotherapy drugs cisplatin and taxol to treat subjects with advanced ovarian cancer. Approximately 5-10 patients will be enrolled locally. Patients will be randomly assigned to receive the chemotherapy drug Taxol over 24 hours or over 96 hours followed by the drug cisplatin. The standard method of giving Taxol is to inject it into a vein slowly over 24 hours, but there is some evidence that giving a slightly lower dose over a longer time may be more effective. Chemotherapy treatments will be repeated every 3 weeks for a total of 6 cycles unless there are excessive side effects or tumor is growing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GOG 169:CISPLATIN VS CISPLATIN + PACLITAXEL IN SQUAMOUS CELL CARCINOM
  • 批准号:
    6265791
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    PATRICIA S BRALY
  • 依托单位:
SEQU3049:STUDY OF DOXIL VS TOPOTECAN HCL IN PATIENTS W/ OVARIAN CANCE
  • 批准号:
    6309599
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    PATRICIA S BRALY
  • 依托单位:
GOG 169:CISPLATIN VS CISPLATIN + PACLITAXEL IN SQUAMOUS CELL CARCINOM
  • 批准号:
    6309581
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    PATRICIA S BRALY
  • 依托单位:
SEQU3049:STUDY OF DOXIL VS TOPOTECAN HCL IN PATIENTS W/ OVARIAN CANCE
  • 批准号:
    6265809
  • 项目类别:
  • 资助金额:
    $1.12万
  • 财政年份:
    1999
  • 负责人:
    PATRICIA S BRALY
  • 依托单位:
海外基金